1. Home
  2. ATGL vs KROS Comparison

ATGL vs KROS Comparison

Compare ATGL & KROS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Alpha Technology Group Limited

ATGL

Alpha Technology Group Limited

HOLD

Current Price

$14.80

Market Cap

246.9M

Sector

N/A

ML Signal

HOLD

Logo Keros Therapeutics Inc.

KROS

Keros Therapeutics Inc.

HOLD

Current Price

$11.17

Market Cap

222.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ATGL
KROS
Founded
2017
2015
Country
Hong Kong
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
246.9M
222.3M
IPO Year
2023
2020

Fundamental Metrics

Financial Performance
Metric
ATGL
KROS
Price
$14.80
$11.17
Analyst Decision
Buy
Analyst Count
0
7
Target Price
N/A
$21.86
AVG Volume (30 Days)
4.3K
321.2K
Earning Date
01-27-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
146.00
EPS
N/A
N/A
Revenue
N/A
$243,864,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$2,751.79
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$9.01
$9.79
52 Week High
$50.00
$22.55

Technical Indicators

Market Signals
Indicator
ATGL
KROS
Relative Strength Index (RSI) 45.56 47.30
Support Level $12.46 $10.47
Resistance Level $20.25 $12.43
Average True Range (ATR) 1.40 0.67
MACD -0.11 0.05
Stochastic Oscillator 22.41 54.96

Price Performance

Historical Comparison
ATGL
KROS

About ATGL Alpha Technology Group Limited

Alpha Technology Group Ltd operates through its subsidiaries, which are established cloud-based IT solution service providers in Hong Kong. Its Operating Subsidiaries utilize its analytic skills, programming skills, artificial intelligence technologies and technological know-how to provide comprehensive solutions designed to optimize the business performance of customers, meet various industry-specific operational challenges of customers and create new business opportunities for customers. The Operating Subsidiaries provide services for customers from a variety of industries, including consulting, real estate, architectural design, carpark management, electronic payment services, logistics, investments, retail, textiles, wholesale and distribution, etc.

About KROS Keros Therapeutics Inc.

Keros Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for patients suffering from hematological, pulmonary, and cardiovascular disorders with high unmet medical needs. The company's protein therapeutic product candidate, KER-050, is being developed for the treatment of low blood cells counts, or cytopenias, including anemia and thrombocytopenia, in patients with myelodysplastic syndromes, or MDS, and in patients with myelofibrosis.

Share on Social Networks: